Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.50)
# 222
Out of 5,127 analysts
112
Total ratings
57.28%
Success rate
19.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $64 → $52 | $23.47 | +121.56% | 4 | Jan 5, 2026 | |
| RZLT Rezolute | Maintains: Buy | $15 → $6 | $2.96 | +102.70% | 4 | Dec 12, 2025 | |
| PHVS Pharvaris | Maintains: Buy | $32 → $39 | $27.06 | +44.12% | 1 | Dec 4, 2025 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $28 → $43 | $23.01 | +86.88% | 8 | Nov 18, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $22 → $19 | $17.63 | +7.77% | 7 | Nov 5, 2025 | |
| LXEO Lexeo Therapeutics | Initiates: Buy | $30 | $6.77 | +343.46% | 1 | Oct 15, 2025 | |
| QURE uniQure | Maintains: Buy | $28 → $95 | $23.47 | +304.77% | 7 | Sep 25, 2025 | |
| PEPG PepGen | Reiterates: Buy | $6 | $5.59 | +7.33% | 2 | Sep 24, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $90 → $92 | $82.28 | +11.81% | 6 | Sep 23, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $19 → $34 | $47.57 | -28.53% | 3 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $106 | $39.77 | +166.53% | 5 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $10 | $8.95 | +11.73% | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $14 | $11.62 | +20.48% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $106 | $59.00 | +79.66% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $558 → $546 | $456.13 | +19.70% | 8 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $16.40 | +204.88% | 5 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $189 | $268.45 | -29.60% | 4 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $55 | $26.00 | +111.54% | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $3.30 | +445.45% | 3 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $11.72 | +45.05% | 2 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $14.31 | +4.86% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Neutral | n/a | $47.25 | - | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $3.68 | +416.30% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $3.65 | +502.74% | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $34.02 | -11.80% | 1 | Jan 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $29 | $1.65 | +1,657.58% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $320.34 | - | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $4.37 | +540.73% | 1 | Dec 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $20 | $13.10 | +52.67% | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $270 → $123 | $34.00 | +261.76% | 8 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $54 | $22.45 | +140.53% | 3 | Jul 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $60 | $1.13 | +5,209.73% | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $26.24 | - | 3 | Jun 26, 2017 |
Ultragenyx Pharmaceutical
Jan 5, 2026
Maintains: Buy
Price Target: $64 → $52
Current: $23.47
Upside: +121.56%
Rezolute
Dec 12, 2025
Maintains: Buy
Price Target: $15 → $6
Current: $2.96
Upside: +102.70%
Pharvaris
Dec 4, 2025
Maintains: Buy
Price Target: $32 → $39
Current: $27.06
Upside: +44.12%
Centessa Pharmaceuticals
Nov 18, 2025
Maintains: Buy
Price Target: $28 → $43
Current: $23.01
Upside: +86.88%
Sarepta Therapeutics
Nov 5, 2025
Maintains: Buy
Price Target: $22 → $19
Current: $17.63
Upside: +7.77%
Lexeo Therapeutics
Oct 15, 2025
Initiates: Buy
Price Target: $30
Current: $6.77
Upside: +343.46%
uniQure
Sep 25, 2025
Maintains: Buy
Price Target: $28 → $95
Current: $23.47
Upside: +304.77%
PepGen
Sep 24, 2025
Reiterates: Buy
Price Target: $6
Current: $5.59
Upside: +7.33%
Ionis Pharmaceuticals
Sep 23, 2025
Maintains: Buy
Price Target: $90 → $92
Current: $82.28
Upside: +11.81%
Maze Therapeutics
Sep 15, 2025
Maintains: Buy
Price Target: $19 → $34
Current: $47.57
Upside: -28.53%
Aug 27, 2025
Reiterates: Buy
Price Target: $106
Current: $39.77
Upside: +166.53%
Aug 14, 2025
Maintains: Buy
Price Target: $40 → $10
Current: $8.95
Upside: +11.73%
Aug 13, 2025
Maintains: Buy
Price Target: $45 → $14
Current: $11.62
Upside: +20.48%
Aug 6, 2025
Maintains: Buy
Price Target: $101 → $106
Current: $59.00
Upside: +79.66%
Aug 6, 2025
Maintains: Buy
Price Target: $558 → $546
Current: $456.13
Upside: +19.70%
Jun 18, 2025
Reiterates: Buy
Price Target: $50
Current: $16.40
Upside: +204.88%
May 7, 2025
Maintains: Buy
Price Target: $195 → $189
Current: $268.45
Upside: -29.60%
May 7, 2025
Maintains: Buy
Price Target: $78 → $55
Current: $26.00
Upside: +111.54%
Dec 3, 2024
Reiterates: Buy
Price Target: $18
Current: $3.30
Upside: +445.45%
Dec 3, 2024
Reiterates: Buy
Price Target: $17
Current: $11.72
Upside: +45.05%
Nov 7, 2024
Maintains: Buy
Price Target: $13 → $15
Current: $14.31
Upside: +4.86%
Jun 28, 2024
Assumes: Neutral
Price Target: n/a
Current: $47.25
Upside: -
Apr 30, 2024
Initiates: Buy
Price Target: $19
Current: $3.68
Upside: +416.30%
Mar 26, 2024
Initiates: Buy
Price Target: $22
Current: $3.65
Upside: +502.74%
Jan 18, 2024
Initiates: Buy
Price Target: $30
Current: $34.02
Upside: -11.80%
Nov 21, 2022
Maintains: Buy
Price Target: $43 → $29
Current: $1.65
Upside: +1,657.58%
Jun 27, 2022
Downgrades: Neutral
Price Target: n/a
Current: $320.34
Upside: -
Dec 16, 2021
Initiates: Buy
Price Target: $28
Current: $4.37
Upside: +540.73%
Dec 15, 2020
Assumes: Buy
Price Target: $20
Current: $13.10
Upside: +52.67%
Aug 24, 2020
Downgrades: Neutral
Price Target: $270 → $123
Current: $34.00
Upside: +261.76%
Jul 9, 2020
Maintains: Buy
Price Target: $60 → $54
Current: $22.45
Upside: +140.53%
Dec 3, 2019
Downgrades: Neutral
Price Target: $60
Current: $1.13
Upside: +5,209.73%
Jun 26, 2017
Downgrades: Neutral
Price Target: n/a
Current: $26.24
Upside: -